If you want to switch horses in the middle of the race, take them to England…
As a foreign spectator of the litigation between Actavis and Eli Lilly (Alimta®) before the English Patents Court (the Hon. Mr. Justice Arnold), this author was fascinated by the ease with which the Court allowed Actavis to add endless new petitions to its declaratory non-infringement action (“DNA”), particularly taking into account that the DNA was…